Newsdesk Follow Medasense’s accomplishments and news Medasense spotlighted as one of Fierce Medtech’s Fierce 15 March 22, 2023 Read More » FDA authorizes marketing of Medasense’s NOL (nociception level index) technology through a De Novo grant February 23, 2023 Read More » New study shows that the odds of suffering severe post-operative pain are six times lower with NOL January 24, 2023 Read More » New study confirms that postoperative pain can be reduced with NOL guided analgesia September 11, 2022 Read More » Study Explores the Ability of NOL Technology to Detect Pain in the ICU January 5, 2022 Read More » Page1 Page2 Page3 Page4 Page5 NEXT Recent Social Media Posts
FDA authorizes marketing of Medasense’s NOL (nociception level index) technology through a De Novo grant February 23, 2023 Read More »
New study shows that the odds of suffering severe post-operative pain are six times lower with NOL January 24, 2023 Read More »
New study confirms that postoperative pain can be reduced with NOL guided analgesia September 11, 2022 Read More »
